| Thomas MA, Preece DM, Bentel JM
Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3'untranslated region. [JOURNAL ARTICLE]
Biochem J 2009 Nov 3.
Abstract | Full Citation | Find Related Articles | | Sabbatini P, Spriggs D, Aghajanian C, et al.
Consolidation strategies in ovarian cancer: Observations for future clinical trials. [JOURNAL ARTICLE]
Gynecol Oncol 2009 Oct 15.
Abstract | Full Citation | | Andrews GP, Abudiak OA, Jones DS
Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. [JOURNAL ARTICLE]
J Pharm Sci 2009 Oct 1.
Abstract | Full Citation | | Sartor O, Gomella LG, Gagnier P, et al.
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: The Therapy Assessed by Rising PSA (TARP) study rationale and design. [Journal Article]
Can J Urol 2009 Oct; 16(5):4806-12.
Abstract | Full Citation | Find Related Articles | | Terada N, Shimizu Y, Yoshida T, et al.
Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft. [JOURNAL ARTICLE]
Prostate 2009 Sep 29.
Abstract | Full Citation | Find Related Articles | | Liu X, Gomez-Pinillos A, Liu X, et al.
Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levels. [JOURNAL ARTICLE]
Prostate 2009 Sep 29.
Abstract | Full Citation | Find Related Articles | | Gravina GL, Biordi L, Martella F, et al.
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer. [Journal Article]
Int J Oncol 2009 Nov; 35(5):1133-9.
Abstract | Full Citation | Find Related Articles | | Pal SK, Twardowski P, Josephson DY
Beyond castration and chemotherapy: Novel approaches to targeting androgen-driven pathways. [JOURNAL ARTICLE]
Maturitas 2009 Sep 4.
Abstract | Full Citation | Find Related Articles | | Ham WS, Cho NH, Kim WT, et al.
Pathological effects of prostate cancer correlate with neuroendocrine differentiation and PTEN expression after bicalutamide monotherapy. [Journal Article, Research Support, Non-U.S. Gov't]
J Urol 2009 Oct; 182(4):1378-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Attar RM, Jure-Kunkel M, Balog A, et al.
Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer. [Journal Article]
Cancer Res 2009 Aug 15; 69(16):6522-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
